Kaada B
Nord Med. 1989;104(6-7):192-8.
It is well documented that placebo represents Pavlovian conditioned reflexes activated by positive anticipation of healing. The pain-relieving effects of placebo are due to a psychical activation of the endogenous opioid-serotonergic, pain-inhibitory descending system. The opposite effect is nocebo, a term introduced in 1961 by Kennedy. Nocebo-effects similarly appear to be produced by conditioned reflexes, but are activated by negative expectations (Figure 1). A number of examples of nocebo are given. Nocebo-stimuli, such as anxiety, fear, mistrust and doubt, may reduce a placebo-effect; it may induce negative side-effects in placebo-treatment; it may produce new aversive symptoms; and it may reverse symptoms from positive ones to negative ones (e.g. revert an analgesic response to hyperalgesia). In its most extreme, nocebo-stimuli may cause death, as in voodoo-death in primitive societies, an example of the fear-paralysis reflex. Whether the outcome is positive or negative is determined, inter alia, by the subject's possibility of coping with the situation. In a setting where the animal has no control over an aversive stimulus, as in inescapable foot shocks, nocebo-effects predominate. It is postulated that noradrenergic neurons in locus coeruleus in the brain stem are involved in the production of nocebo-effects. The "placebo-system" and the "nocebo-system" exert a reciprocal inhibition at a brainstem level (Figure 3).
有充分文献记载,安慰剂代表由对治愈的积极预期所激活的巴甫洛夫条件反射。安慰剂的止痛效果归因于内源性阿片 - 血清素能疼痛抑制下行系统的心理激活。相反的效应是反安慰剂,这一术语由肯尼迪于1961年提出。反安慰剂效应同样似乎是由条件反射产生的,但由消极预期所激活(图1)。给出了一些反安慰剂的例子。反安慰剂刺激,如焦虑、恐惧、不信任和怀疑,可能会降低安慰剂效应;它可能在安慰剂治疗中诱发负面副作用;它可能产生新的厌恶症状;并且它可能使症状从积极变为消极(例如,将镇痛反应转变为痛觉过敏)。在最极端的情况下,反安慰剂刺激可能导致死亡,如原始社会中的巫毒死亡,这是恐惧麻痹反射的一个例子。结果是积极还是消极,尤其取决于个体应对该情况的可能性。在动物对厌恶刺激无法控制的情况下,如不可逃避的足部电击,反安慰剂效应占主导。据推测,脑干蓝斑中的去甲肾上腺素能神经元参与了反安慰剂效应的产生。“安慰剂系统”和“反安慰剂系统”在脑干水平上相互抑制(图3)。